Personalis Corp - PSNL Price Chart

This chart of the market valuation of Personalis, Inc. (PSNL) on the GURU.Markets platform, where the indicator stands at 15.67, showcases a company implementing genetic screenings to optimize therapy. The business relies on its own high-tech sequencing base in the US with strict environmental controls. Despite competing with diagnostic behemoths, the firm maintains its position through exclusive patents and strategic alliances.

Share Price: Personalis, Inc. (PSNL) for 07/04/2022 - 11/14/2026

Metric breakdowns and analytics for Personalis Inc (PSNL)

- stock value and consensus price forecast:

Price Chart Personalis, Inc.|PSNL - Forecast Levels Chart

- issuer market value details:

Market Value Personalis Inc|PSNL - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share Personalis|PSNL - Accounting Capitalization|Market Value to Book Value Ratio personalis.com|PSNL - Aggregate Company Assets

- debt and liquidity details:

- company profitability and valuation multiples indicators:

PSNL - Company Net Income|Expected Profit Personalis, Inc.|PSNL - Company Value to Net Income|Projected Price to Earnings Personalis|PSNL - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Personalis Inc|PSNL - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Personalis|PSNL - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months personalis.com|PSNL - Earnings per share increase in current year|Earnings growth forecast for next year Personalis, Inc.

- sales revenue and business income indicators:

PSNL - Company Total Revenue|Company Projected Revenue Personalis, Inc.|PSNL - Price-to-Sales Ratio|Forward P/S Multiple Personalis Inc

Comprehensive company analysis:PSNL Personalis, Inc.

Price action reflects the current valuation of Personalis, Inc. (PSNL) by major institutional investors. This indicator captures the market equilibrium of supply and demand, aggregating all fundamental expectations. By analyzing the price trend, one can assess the market value of the company's patents in the genomic sequencing sector. The share price correlates with the success of the struggle for dominance over universal laboratories, making the asset sensitive to technological breakthroughs.

Who Personalis, Inc. competes with